Peter Leonard Grant

Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom.

Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom.

Asterion Ltd. develops novel therapeutic products. It offers drugs for patients with chronic, debilitating diseases. The company was founded by Richard John Martin Ross, Peter Artymiuk and Jon R. Sayers in 2001 and is headquartered in Sheffield, the United Kingdom.

Genophrenix Ltd. discovered and developed proteins for neurological diseases. The company was founded on February 20, 2006 and was headquartered in Sheffield, the United Kingdom.

Phase Focus Ltd. provides optical prototype instruments. It brings to market a range of products and services based on its proprietary Phasefocus Virtual Lens- a disruptive technology that is revolutionising the performance of imaging instrumentation and bringing new user value to analytical applications from stain-free cell imaging and quantitative electron phase microscopy to ophthalmic lens metrology and beyond. The firm's Virtual Lens enables the observation and analysis of materials, processes and products in new ways and with unprecedented clarity and accuracy. The company was founded in 2006 and is headquartered in Sheffield, the United Kingdom.

Part of IP Group Plc, Fusion IP Cardiff Ltd. engages in the commercialization of intellectual property. The private company is based in London, UK. The British company was founded by Neil Warren.

Part of IP Group Plc, Fusion IP Sheffield Ltd. commercializes intellectual properties. The private company is based in London, UK.

Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom.

Progenteq Ltd. develops a novel cartiledge replacement therapy to revolutionize the treatment of acute knee injuries. The company was founded on November 29, 2009 and is headquartered in Cardiff, the United Kingdom.

PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom.

FaultCurrent Ltd. develops magnetic fault current limiter protection products. It offers passive magnetic fault current limiter (pmFCL), a Smart Grid technology that protects utility electrical distribution networks from unanticipated power surges and the new demands being placed on ageing and already overburdened electrical infrastructures from the connection of cleaner distributed energy sources. The company was founded by Jeremy Hall in 2012 and is headquartered in Caerphilly, the United Kingdom.